A healthy dose of Inno-vation


Cheah: The long-term aim is to drive breakthroughs in areas like vaccine development, advanced cell culture systems and translational research for regenerative medicine.

SINCE his school days, Evan Cheah has been passionate about science. It is no surprise, then, that after earning two master’s degrees and a PhD in Health Science, he established his own startup, Inno Therapeutics, in 2018.

Inno Therapeutics specialises in drug development, vaccine innovation, and cellular therapeutic research, development, and manufacturing.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

MUI Bhd to take asset-light strategy with Corus KLCC hotel sale
Ecobuilt sells Kapar land for RM5.74mil to reduce debt
SCIB sells concrete subsidiary to YTL Cement for RM113mil
Dialog expects challenging economic environment ahead
BAT Malaysia to raise cigarette prices from Nov 21
Paramount’s 3Q25 net profit up more than 50%
Critical Holdings acquires land in Penang for RM11.5mil
Ringgit extends technical correction, ends lower as US rate outlook remains uncertain
Lianson Fleet Group partners with PetroVietnam to explore JV in offshore drilling
Dialog Group expands Pengerang Deepwater Terminals with BP deal

Others Also Read